This compound is a pharmaceutical intermediate used in the synthesis of antifolate agents. It contains a pteridine ring system and ester functional groups, consistent with its role in building folate analogs.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 146464-91-7
2-Ethyl-2-adamantanol
pharmaceutical intermediate
4,6-Dichloro-5-(4-bromophenyl)pyrimidine
pharmaceutical intermediate
2-Cyclopropyl-3-[(diphenylphosphinyl)methyl]-4-(4-fluorophenyl)quinoline
pharmaceutical intermediate
Aspirin anhydride
pharmaceutical intermediate
Pralatrexate
pharmaceutical raw material
methyl 4-[2-[(2,4-diaminopteridin-6-yl)methyl]-1-methoxy-1-oxopent-4-yn-2-yl]benzoate
DDPOXTVFAFZLJO-UHFFFAOYSA-N
COC(=O)C1=CC=C(C=C1)C(CC#C)(CC2=CN=C3C(=N2)C(=NC(=N3)N)N)C(=O)OC
—